PUBLIC CONTRACT · 2022
Ruxolitinib 15MG comp
- Contract value
- €11,755.25
- Signed on
- 29 March 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9185444PUBLISHED SUBJECT
RUXOLITINIB 15MG COMP
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Viseu, Viseu
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA · Tax ID 500063524
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €11,755.25
- Procedure base price
- €11,755.25
- Total effective price
- Not reported on Portal BASE
- Publication date
- 14 April 2022
- Award date
- 29 March 2022
- Signing date
- 29 March 2022
- Performance period
- 153 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33650000-1 - Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5865659
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.